#LetsBeBlunt, #MontelWilliams, #CannabisScience
Cannabis is back in the headlines — but not for the reasons you might expect.
From alarming stories about Cannabinoid Hyperemesis Syndrome (CHS) to growing concerns around contamination and product safety, the public conversation is getting louder… but not necessarily clearer.
In this episode of Let’s Be Blunt with Montel, Montel sits down with cannabis scientist Kyle Boyar to separate fact from fear.
With over a decade of experience in microbiology, analytical chemistry, and cannabis testing, Kyle brings a grounded, evidence-based perspective to some of the most misunderstood topics in the industry today.
Together, they unpack what science actually says about CHS — what we know, what we don’t, and why some popular theories may be missing the mark. They also dive into cannabis microbial testing, including new research on Aspergillus and mycotoxins, and explore whether current safety standards are truly protecting consumers — or simply checking boxes.
The conversation goes even deeper into the rise of remediation technologies used to pass compliance testing, and what that could mean for product quality and long-term safety.
And if you think terpenes tell the whole story when it comes to cannabis aroma — think again. New research is challenging long-held assumptions about what really drives the scent and experience of cannabis.
This is a conversation about science, uncertainty, and the importance of getting it right.
Because when it comes to cannabis — the truth is more nuanced than the headlines.
🔑 Key Topics Covered
- Cannabinoid Hyperemesis Syndrome (CHS): facts vs media narratives
- The neem oil hypothesis and other debated causes
- Cannabis microbial testing and safety gaps
- Aspergillus and mycotoxin detection trends
- Remediation technologies and their unintended consequences
- The evolving science of cannabis aroma beyond terpenes
- Why cannabis research still has major blind spots
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
